BACKGROUND Increasing access to safe abortion services is the most effective way of preventing the burden of unsafe abortion, which is achieved by increasing safe choices for pregnancy termination. Medical abortion for termination of early abortion is said to safe, effective, and acceptable to women in several countries. In Ethiopia, however, medical methods have, until recently, never been use...

The aim of this study is to explore women's experiences and perceptions of home use of misoprostol and of the self-assessment of the outcome of early medical abortion in a low-resource setting in India. In-depth interviews were conducted with 20 women seeking early medical abortion, who administered misoprostol at home and assessed their own outcome of abortion using a low-sensitivity pregnancy...

BACKGROUND Nepal government has approved medical abortion and manual vacuum aspiration for early first trimester pregnancy. Both the procedures have been approved by World Health Organization for use in early first trimester. OBJECTIVES The study aims to compare efficacy and safety of medical abortion with surgical abortion in a district hospital of rural eastern Nepal. METHOD An observatio...

BACKGROUND Despite being legally available in India since 1971, barriers to safe and legal abortion remain, and unsafe and/or illegal abortion continues to be a problem. Community health workers have been involved in improving access to health information and care for maternal and child health in resource poor settings, but their role in facilitating accurate information about and access to saf...

BACKGROUND A combination of mifepristone followed after 24 hrs by misoprostol has proved a safe and effective abortifacient for termination of early pregnancy. Home use of misoprostol for medical abortion is still controversial in many countries including ours where women's literacy rate is low. Particularly in developing countries, this method markedly decreased the hospital visit which would ...

Abstract Early into the COVID -19 pandemic, abortion rights advocates highlighted importance of maintaining access to through telemedicine. It was argued that telemedical and self-managed was, in pandemic context, a human imperative. This article argues providing for remains imperative beyond duration pandemic. Telemedical is safe effective, supports pregnant person’s preferences reproductive a...

Cameron et al.1 report on a pilot of early medical abortion in a group of women with pregnancies less than 8 weeks. They demonstrated good patient experiences and high levels of satisfaction in this group of women; in the immediate aftermath of the abortion. I do, however, have serious concerns regarding their administration of mifepristone right away, on the same day, following patient assessm...

We write in support of using mifepristone at the fi rst visit for early medical abortion (EMA), without an obligatory cooling-off period.1 In our service in South East Wales, we have been providing home EMA since 2007 in a setting very similar to that described in the pilot study reported by Cameron et al.2 Similarly, patients attending our service are able to have mifepristone administered at ...